Back to Nephrology
Nephrologyv2007Evidence-Based

AKIN Classification for Acute Kidney Injury (AKI)

Classifies severity of acute kidney injury based on serum creatinine and urine output criteria within 48 hours

Clinical Input Parameters

mg/dL
Range: 0.1 — 15 mg/dL
mg/dL
Range: 0.1 — 15 mg/dL
mg/dL
Range: 0 — 10 mg/dL
mL/kg
Range: 0 — 50 mL/kg
mL/kg
Range: 0 — 100 mL/kg
mL/kg
Range: 0 — 200 mL/kg
Clinical Assessment
Awaiting Parameters
akin stage
—stage
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The AKIN Classification for Acute Kidney Injury (AKI) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within nephrology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Stage 1: Cr ≥0.3 mg/dL increase or 1.5-2x baseline OR UO <0.5 mL/kg/hr x >6h; Stage 2: Cr 2-3x baseline OR UO <0.5 mL/kg/hr x >12h; Stage 3: Cr >3x baseline or ≥4.0 mg/dL with acute increase ≥0.5 mg/dL OR UO <0.3 mL/kg/hr x ≥24h or anuria x 12h OR RRT

Clinical Pearls & Practice Notes

  • AKIN classification requires changes within 48 hours
  • Diagnosis requires adequate hydration and exclusion of urinary obstruction
  • Patients on RRT are automatically classified as Stage 3
  • Two creatinine measurements within 48 hours are required
  • Baseline creatinine not required - can use first reference reading
  • Stage corresponds to highest criterion met (creatinine or urine output)
  • More sensitive than RIFLE for detecting mild AKI
  • Associated with increased mortality even at Stage 1
  • Important for clinical decision-making and prognosis
  • Should be used with clinical context and other assessments

Evidence & Literature Citations

  1. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.
  2. Lopes JA, Jorge S. The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J. 2013;6(1):8-14.
  3. Xiong J, Tang X, Hu Z, et al. The RIFLE versus AKIN classification for incidence and mortality of acute kidney injury in critical ill patients: A meta-analysis. Sci Rep. 2015;5:17917.

Score Interpretation Ranges

No AKI0 – 0 pts

No acute kidney injury

Stage 11 – 1 pts

Mild AKI

Stage 22 – 2 pts

Moderate AKI

Stage 33 – 3 pts

Severe AKI

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.